ULBI.NASDAQUltralife CORP

10-Q: Ultralife Corp. Q2 2026: Profitability Up, Backlog Hits Record

Sentiment:

Quarterly Report


Ultralife Corporation reported improved gross margins and net income in Q2 2026 compared to the prior year, driven by favorable product mix and tariff refunds, with a record backlog of $117.5 million.

Capital raiseThe company has an effective shelf registration statement on Form S-3 (File No. 333-278360) allowing for the offering and sale of securities from time to time.The New Registration Statement includes $100,000,000 of unsold securities from a prior registration statement.Proceeds from any future sales may be used for general corporate purposes, including potential acquisitions, strategic capital expenditures, and product development.
Better than expectedNet income attributable to Ultralife Corporation increased to $2.5 million ($0.15 per share) in Q2 2026 from $0.9 million ($0.05 per share) in Q2 2025.Gross profit margin improved significantly to 28.9% in Q2 2026 from 23.9% in Q2 2025.Operating income increased to $3.4 million (7.2% of revenue) in Q2 2026 from $2.3 million (4.6% of revenue) in Q2 2025.The company achieved a record backlog of $117.5 million at the end of Q2 2026.

Summary

  • Ultralife Corporation reported Q2 2026 revenues of $47.9 million, a slight decrease of 1.3% from $48.6 million in Q2 2025.
  • Gross profit increased to $13.9 million (28.9% of revenue) from $11.6 million (23.9% of revenue) year-over-year.
  • Net income attributable to Ultralife Corporation was $2.5 million ($0.15 per share) for Q2 2026, up from $0.9 million ($0.05 per share) in Q2 2025.
  • The company's total backlog reached a record $117.5 million at the end of Q2 2026.
  • Operating expenses increased due to R&D investments and one-time costs, but operating income improved significantly.
  • A material weakness in internal control over financial reporting persists, related to accounting personnel expertise and IT general controls.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting improved profitability and gross margins, alongside a record backlog, despite a slight revenue dip. The company is actively managing debt and investing in R&D, though a material weakness in internal controls remains a concern.

Positives

  • Gross profit margin improved significantly to 28.9% in Q2 2026 from 23.9% in Q2 2025, driven by favorable product mix and IEEPA tariff refunds.
  • Net income attributable to Ultralife Corporation increased to $2.5 million ($0.15 per share) in Q2 2026 from $0.9 million ($0.05 per share) in Q2 2025.
  • The company achieved a record backlog of $117.5 million at the end of Q2 2026.
  • Operating income rose to $3.4 million (7.2% of revenue) in Q2 2026 from $2.3 million (4.6% of revenue) in Q2 2025.
  • Interest and financing expenses decreased due to the paydown of the term loan.
  • The company recognized a net refund of $1.1 million for previously paid IEEPA tariffs.

Negatives

  • Consolidated revenues decreased by 1.3% to $47.9 million in Q2 2026 compared to $48.6 million in Q2 2025.
  • Operating expenses increased by 11.6% to $10.4 million in Q2 2026, driven by R&D investments and one-time non-recurring costs.
  • A material weakness in internal control over financial reporting persists, impacting the effectiveness of disclosure controls and procedures.
  • Cash decreased to $6.7 million at June 30, 2026, from $9.3 million at December 31, 2025, primarily due to debt payments.

Risks

  • Uncertain global economic conditions, including inflation, tariffs, interest rates, and supply chain disruptions.
  • Reliance on certain key customers for a significant portion of revenues.
  • Potential disruptions or delays in the supply of raw materials and components, or material increases in their costs.
  • Safety risks associated with Lithium batteries, including fire hazards.
  • Variability in quarterly and annual results and potential fluctuations in stock price.
  • Inability to comply with changes to regulations for product shipment.
  • Potential impairments of goodwill and other intangible assets.
  • Exposure to foreign currency fluctuations.

Future Outlook

The company expects positive operating cash flow and availability under its Revolving Credit Facility to meet general funding requirements. It intends to use proceeds from potential future securities sales for general corporate purposes, including acquisitions, capital expenditures, and product development.

Management Comments

  • StockSavvy.ai notes the company's rebranding initiative aims to consolidate sub-brands under a singular, unified master brand 'Ultralife' to enhance clarity, consistency, and brand equity.
  • Management believes the company is positioned for ongoing growth and stronger market impact by leading in mission-critical battery and RF power solutions.
  • The company is focused on converting new product development efforts into revenue, maintaining operational efficiency, and advancing vertical integration to deliver sustainable profitable growth and reduce debt.

Industry Context

StockSavvy.ai observes that Ultralife operates in the battery and communications systems sectors, facing industry trends such as increased demand for mission-critical power solutions, evolving government and defense procurement, and ongoing supply chain complexities. The company's rebranding aligns with a broader industry trend of simplifying corporate identity to enhance market recognition.

Comparison to Industry Standards

  • Gross margins improved to 28.9% in Q2 2026, which is a positive development, though direct comparison to industry peers requires specific segment data not fully detailed here.
  • The record backlog of $117.5 million suggests strong demand, potentially outperforming segments of the broader industrial manufacturing sector that may be experiencing slower growth.
  • Increased R&D spending as a percentage of revenue indicates a commitment to innovation, a common strategy among leading companies in the technology and manufacturing sectors to maintain competitive advantage.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control Material WeaknessA material weakness in internal control over financial reporting persists due to insufficient accounting personnel expertise and ineffective IT general controls. Remediation efforts are ongoing.June 30, 2026Potential for misstatements in financial reporting not being prevented or detected in a timely manner. Management believes financial statements are fairly stated despite this weakness.

Legal Proceedings

  • The company is subject to legal proceedings and claims that arise from time to time in the normal course of business. Management believes the final disposition of these matters will not have a material adverse effect, but acknowledges inherent uncertainties.

Stakeholder Impact

  • Shareholders: Improved profitability and a record backlog are positive indicators, but the ongoing material weakness in internal controls may raise concerns about financial reporting reliability.
  • Creditors: The company is actively reducing debt and has sufficient liquidity, with compliance on debt covenants.
  • Employees: Increased R&D investment suggests a focus on future growth, potentially leading to new opportunities. However, the material weakness in controls could imply operational challenges.
  • Customers: The company's focus on mission-critical power solutions and rebranding aims to enhance customer recognition and service.

Next Steps

  • Continue to convert long-term new product development efforts into revenue.
  • Maintain a strong focus on operational efficiency initiatives to improve gross margins.
  • Advance vertical integration in the oil & gas segment.
  • Execute on backlog replenishment.
  • Continue to invest in new product development.
  • Actively implement corrective actions to remediate identified ITGC deficiencies.
  • Formalize user access reviews and require more frequent and timely performance.

Key Dates

DateDescription
2021-12-13KeyBank National Association entered into a Credit and Security Agreement.
2024-10-31Closing of the acquisition of Electrochem and borrowing of the full amount of the Term Loan Facility.
2025-03-29Company filed a new shelf registration statement on Form S-3.
2025-04-02Prior shelf registration statement was set to expire.
2025-05-07New shelf registration statement declared effective by the SEC.
2025-10-01Ultralife decided to undergo a comprehensive rebranding initiative.
2026-06-30End of the quarterly period covered by the report.
2026-08-07Date of the report signatures.

Recommendation

hold

The company shows improved profitability and a record backlog, indicating positive operational momentum. However, the persistent material weakness in internal controls and a slight revenue decline warrant a cautious approach. A 'hold' recommendation reflects the balance between these positive and negative factors, pending full remediation of control issues and sustained revenue growth.

Keywords

Batteries, Communications Systems, Power Solutions, Government Contracts, Defense, Rechargeable Batteries, Non-rechargeable Batteries, Tariff Refunds

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.